#Sneddon syndrome (SS) is a rare non-inflammatory obliterative #vasculopathy, characterised by the association of #cardiovascular (arterial hypertension, intermittent claudication, and coronary artery disease) and #neurological events (ischaemic #stroke, headache, dizziness and

The new ACR guideline for the management of #lupusnephritis is out! Recommendation for triple-drug therapies (anti-B cell or CNI) & reduced dose steroids (pulse methylpred and 0.5mg/kg prednisone, max 40mg). acrjournals.onlinelibrary.wiley.com/doi/abs/10.100… . .

Review article shows that in psoriasis pts, adding #MTX to TNFi increases efficacy, but there is limited data on adding MTX to either IL-17 or IL-23. But in Psoriatic Arthritis (PsA), adding MTX provides no added efficacy compared to biologic monotherapy buff.ly/Mm1hnHT

As of today, there is now an FDA approved treatment for #IgG4RD! Such an exciting time for patients living with IgG4-related disease. amgen.com/newsroom/press…

Case-control study aimed to identify optimal PJP prophylaxis schedule in patients with rheumatic diseases. Tapering GCs with 12.5 mg/day of prednisone equivalent could be a reasonable timepoint to initiate withdrawal of PJP prophylaxis A&R doi.org/10.1002/art.43…

Autoimmune Diseases & Pregnancy: What You Should Know Women with scleroderma, vasculitis, or Sjögren’s need pre-pregnancy evaluation by a multidisciplinary team. ✅Assess risks ✅Plan treatment ✅Protect mom & baby Tailored care = safer pregnancy journals.lww.com/jclinrheum/ful…

New Horizons in Systemic Sclerosis treatment: advances and emerging therapies in 2025 ⭐ Systemic sclerosis (SSc) remains one of the most complex autoimmune diseases to treat, with multisystem involvement and limited therapeutic options This review charts the shift from broad

Secukinumab fails in GCA phase 3 RCT. Novartis announced top-line results from the GCAptAIN study evaluating secukinumab in adults with newly diagnosed or relapsing GCA. In a steroid taper RCT, the endpoint was sustained remission at Wk 52 compared to placebo

CRYSTAL ARTHRITIS IN THE DIFFERENTIAL DIAGNOSIS OF NECK PAIN: A CASE OF CROWNED DENS SYNDROME | Anti-Aging Eastern Europe Genç TRASD Abdulvahap Kahveci Dr.ismihan Zeljka Kardum Halise Hande Gezer Gul Sandal Uzun Mrunylina (Tsvetelina Velikova) Prakashini Sakir Ahmed antiagingeeu.com/index.php/jour…

Take the #EXPLOREPsA survey 🧭 — led by #YoungGRAPPA to learn how PsA disease activity is assessed globally. 🕐 5–10 min 🌍 Worldwide participation welcome 🔗app.onlinesurveys.jisc.ac.uk/s/oxford/explo… GRAPPA Network - Official Cristina Macía Rheum Cat Laurent ARNAUD

Please Complete the survey if you are a rheumatologist or health professional managing PsA patients. 🔗 Take the survey: app.onlinesurveys.jisc.ac.uk/s/oxford/explo…

Join the EXPLORE-PsA survey! This is the first global research project led by Young GRAPPA, aiming to understand how PsA activity is assessed in everyday clinical practice. Your voice can help shape future tools and improve PsA care worldwide! app.onlinesurveys.jisc.ac.uk/s/oxford/explo…

Join our efforts 🙌🏻

See you at Luxor 2026

Dear Rheumatologists, we notified you before that we plan to have our 48th ESRd Conference at Hurghada on 26 June. But we have to do a big change in date and location. 48th ESRd Conference will be held on 9 February 2026 to 13 Feb. at Luxor, Egypt.

🌸 Malar rash + joint pain? Think Lupus. Check: ANA ✅, anti-dsDNA 🧬, complements 💧, urinalysis 🧪. Don’t miss the differentials — rosacea, dermatomyositis, seborrheic dermatitis. Early diagnosis = better outcomes. #MedTwitter #LupusAwareness Dr Ihab Suliman Dr. Akhil 🇮🇳

ان شاء الله هاكون موجودة من الاسبوع القادم في عيادات مستشفي دار الفؤاد فرع مدينة نصر. متاح كافة التعاقدات والنقابات. للحجز والاستعلام اونلاين ... bit.ly/3OgPqo1 واتساب 01100216370 الخط الساخن 16370

Thanx National Psoriasis Foundation for accepting and sponsoring my attendance to FUTURE LEADERS IN PSORIATIC DISEASE. I had a great time of networking, updates, comanagement with dermatology, and interactive cases. Special thanks to Y- GRAPPA Network - Official, André Ribeiro and Stephanie Corder

Are we putting the CAR-T before the horse? CAR T-cells have been a revolutionary development in rheumatology. We have seen a population of patients with severe refractory autoimmune conditions almost overnight presented with the prospect of not just improvement, but of a cure.

🧪✨ Major Trials of DOACs in Antiphospholipid Syndrome (APS) 1️⃣ 🪤 TRAPS Trial (Rivaroxaban in High-Risk APS) 👥 Population • 🔺 Triple-positive APS (LA 🧪 + aCL 🎯 + anti-β2GP1 🧿) • ⚡ High-risk group • 🩸 Prior arterial + venous thrombosis 🧪 Design • 💊 Rivaroxaban